AGEN, AGE To Battle Coronavirus, BCLI Awaits ALS Trial Data, FDA Delays Decision On NVS' Drug

Today's Daily Dose brings you news about Agenus' foray into COVID-19 drug development space; AMERI Holdings' progress in glioblastoma multiforme drug development; BrainStorm Cell's anticipated milestone related to its amyotrophic lateral sclerosis drug candidate; Citius Pharma's path forward for antibiotic lock solution; Novartis' revised FDA decision date and stock offerings of EvoFem and OraSure

from RTT - Biotech https://ift.tt/3gM4VRL
via IFTTT